NBNautilus Biotechnology Team
Nautilus Biotechnology
Last updated: February 23, 2026
Nautilus Biotechnology offers a high-throughput, low-cost platform for analyzing and quantifying the human proteome. Biotech
Andreessen Horowitz, Post-IPO, $470M valuation
Nautilus Biotechnology offers a high-throughput, low-cost platform for analyzing and quantifying the human proteome. Biotech
Andreessen Horowitz, Post-IPO, $470M valuation
- IPO • Andreessen Horowitz, Post-IPO, $470M valuation
Founder Intelligence Brief: Nautilus Biotechnology Team
This profile is built to help readers move from a founder name to decision-ready context. Nautilus Biotechnology Team is mapped to Nautilus Biotechnology in the Startup category, with current stage context as Ipo. The primary operating market is San Francisco Bay Area, California, USA, which connects this profile directly to regional ecosystem pages and related industry hubs.
Funding visibility currently shows $470.00M, with the latest mapped round as IPO (Andreessen Horowitz, Post-IPO, $470M valuation). This makes it easier to evaluate growth narrative against capital stage rather than reading isolated updates without baseline context.
For deeper research, combine this founder page with the company profile, company news hub, country newsroom and Startup startup list. This route gives a cleaner picture of execution, market demand, and competitive movement.
Research flow
- Validate company baseline on company intelligence.
- Compare market peers via Startup industry routes and Ipo stage pages.
- Track fresh updates in newsroom coverage and signals feed.
Operating context
- Geography: United States directory.
- Stage signal: Ipo funding coverage.
- Hiring status: Open Roles.
Related Founders
More founders in Startup.
Want to get featured on 100Xfounder?
Get your founder profile published with verified funding and hiring context.
Related Pillar Pages
Access the country, industry, stage, startup taxonomy, and newsroom routes connected to this founder.
FAQs About Nautilus Biotechnology Team
Common questions people ask about this profile.
Who is Nautilus Biotechnology Team?
Nautilus Biotechnology Team is the founder profile listed on 100Xfounder for Nautilus Biotechnology, tracked for market signals, company intelligence, and operator-level context.
What does Nautilus Biotechnology do?
Nautilus Biotechnology offers a high-throughput, low-cost platform for analyzing and quantifying the human proteome. Biotech
Where is Nautilus Biotechnology based?
Nautilus Biotechnology is listed as operating from San Francisco Bay Area, California, USA.
What is the current funding stage of Nautilus Biotechnology?
Nautilus Biotechnology is currently categorized at Ipo on 100Xfounder. Funding signal: Andreessen Horowitz, Post-IPO, $470M valuation
What is the latest funding round for Nautilus Biotechnology?
The latest tracked round for Nautilus Biotechnology is IPO Andreessen Horowitz, Post-IPO, $470M valuation. Total tracked rounds: 1.
Is Nautilus Biotechnology hiring right now?
Current hiring signal for Nautilus Biotechnology: Open Roles.
Is Nautilus Biotechnology Team's profile verified?
Yes. Nautilus Biotechnology Team's profile is marked as verified on 100Xfounder as of July 23, 2026.
How can I connect with Nautilus Biotechnology Team?
You can use the profile action buttons and listed links on 100Xfounder. Contact context is provided with business relevance and profile metadata for www.nautilus.bio.
What technologies are associated with Nautilus Biotechnology?
Nautilus Biotechnology is associated with AWS, React, Python, and PostgreSQL based on current profile intelligence.